Journals / MN Oftalmoloji / 1996 / Cilt: 3 - Sayı: 4

The use of mitomycine-c in the recurrent pterygium cases

Nüks pterjiumlu olgularda mitomisin-c kullanımı

Pages
345–346
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Complications wern't seen, exclude 1 (%6.6) punctate keratopathy and 2 (%13.3) recurrence.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Surgical excision of the pterygium is insuffient in it's treatment and recurrences after excision may be nen.
📊
Key Findings & Data:In our clinic, 15 patients with recurrent pterygium were treated with 0.2 mg/ml mitomidn eye drops (three times in a day, for 7 days).
💡
Conclusion & Impact:Complications wern't seen, exclude 1 (%6.6) punctate keratopathy and 2 (%13.3) recurrence.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Surgical excision of the pterygium is insuffient in it's treatment and recurrences after excision may be nen. Because of recurrence, the use of local mitomi-dn-C therapy after surgical excision is useful. In our clinic, 15 patients with recurrent pterygium were treated with 0.2 mg/ml mitomidn eye drops (three times in a day, for 7 days). The results were evalua¬ted about complications and postoperative recur¬rences. Average postoperative follow-up was 10 months. Complications wern't seen, exclude 1 (%6.6) punctate keratopathy and 2 (%13.3) recurrence.

Özet

Pterjium tedavisi kesin iyileşme ile sonuçlanmamakta ve nttksler görülebilmektedir. Nüks olgularında cerrahi tedavi yeterli sonuç sağlayamadığından, postoperatif topikal mitomisin-c kullanımı re-kttrrensi önlemede yararlı olabilmektedir. Kliniğimizde, nüks pter¬jiumlu 15 hastaya klasik pterjium eksizyonundan sonra 7 gün sü¬reyle günde 3 kez bir damla şeklinde mitomisin-c (0.2 mg/ml) uy¬gulandı. Sonuçlar, postoperatif nüks oranı ve komplikasyonlar açı¬sından değerlendirildi. Ortalama 10 aylık takip sonrasında, 2 (%13.3) olguda nüks ve 1 (%6.6) olguda da punktat keratopati dışında herhangi bir kompli-kasyona rastlanılmadı.

🔖

Cite This Article

SAK, A., KARAKAŞ, N., SÖKER, S. (1996). The use of mitomycine-c in the recurrent pterygium cases. MN Oftalmoloji, Cilt: 3 - Sayı: 4, 345–346. https://ajindex.com/articles/296659